ERK1/2: Function, signaling and implication in pain and pain-related anxio-depressive disorders.
Despite the increasing knowledge regarding pain modulation, the understanding of the mechanisms behind a complex and pathologic chronic pain condition is still insufficient. These knowledge gaps might result in ineffective therapeutic approaches to relieve painful sensations. As a result, severe untreated chronic pain frequently triggers the onset of new disorders such as depression and/or anxiety, and therefore, both the diagnosis and treatment of patients suffering from chronic pain become seriously compromised, prompting a self-perpetuating cycle of symptomatology. The extracellular signal-regulated kinases 1 and 2 (ERK1/2) are molecules strongly implicated in the somatic component of pain at the spinal cord level and have been emerging as mediators of the emotional-affective component as well. Although these molecules might represent good biomarkers, their use as pharmacological targets is still open to discussion as paradoxical information has been obtained. Here we review the current scientific literature regarding ERK1/2 signaling in the modulation of pain, depression and anxiety, including the emotional-affective spheres of the pain experience.
['Borges|Gisela|G|', 'Berrocoso|Esther|E|', 'Mico|Juan Antonio|JA|', 'Neto|Fani|F|']
D000818:Animals D006801:Humans D048052:Mitogen-Activated Protein Kinase 3 D019964:Mood Disorders D010146:Pain D015398:Signal Transduction D013116:Spinal Cord
Chronic pain Depression Anxiety Paragigantocellularis–locus coeruleus–prefrontal cortex pathway pERK1/2